The browser you are currently using is out of date.

To ensure the best possible experience using our website, please upgrade to a newer version.

Internet Explorer Firefox
RSS

4Life Digital NewsStand

Share

Tuesday, January 08, 2013

4Life Transfer Factor® Products in 2013 PDR

Salt Lake City, Utah (January 8, 2013) 4Life executives are pleased to announce that 4Life Transfer Factor® products are listed in the 2013 Physician’s Desk Reference (PDR).

“We are thrilled to be part of this prestigious and valuable publication. This is the ninth year that 4Life products have been listed,” stated Director of Product Development Chad Renshaw. “The PDR is among the most substantiated resources in the medical community and is distributed to 500,000 health professionals across the United States. Having 4Life products included provides distributors with unrivaled credibility when presenting our products to customers.”

The 2013 edition of the PDR provides in-depth product information about 4Life Transfer Factor® and 4Life® Transfer Factor Plus® Tri-Factor® Formulas. In addition, the publication offers a technical description of the product line and synopses on several scientific studies.

With nine worldwide patents and dozens more pending, an in-house Research and Development team, the scientific input of the Health Sciences Advisory Board, and the industry’s only immunological testing lab, 4Life’s commitment to Transfer Factor science is well established.

Director of Health Information Systems Brent Vaughan: “This professional listing is an invaluable asset for 4Life distributors. The publication strengthens the field’s position as exclusive leaders in the distribution of 4Life Transfer Factor products.”

4Life has offices on five continents to serve a global network of independent distributors through science, success, and service.

For more information:
Calvin Jolley
Vice President, Communications
4Life Research USA, LLC
CalvinJolley@4life.com

© 2013 4Life Trademarks, LLC

The information on this website is only applicable in the United States.

View Mobile Site

Please select a category and fill out the comments.